

Most Read This Week
- Mediterranean and Low-Fat Diet for Long-Term Secondary Prevention of Cardiovascular Disease
- Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease
- Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide
- Diabetes Screening by Race and Ethnicity in the United States
- Risk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D
Recently Updated
- Risk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D
- Weight Change During the Post-Intervention Follow-Up of Look AHEAD
- Factors Associated With Weight Loss in People With Type 2 Diabetes and Overweight or Obesity
- Cardiovascular Benefits of GLP-1RA and SGLT-2i in Women With Type 2 Diabetes
- Association Between Obesity and Macrovascular and Microvascular Complications of Diabetes